The Heart Hive - Cardiomyopathy Study

Status Recruiting

Clinical Trial Summary

This is an online registry and database of patients with cardiomyopathy and myocarditis, coupled with an observational study of DCM and HCM.

Clinical Trial Description

This study utilises The Heart Hive, an international, online registry of patients with self-reported clinically diagnosed cardiomyopathy or myocarditis, and people with a family history of cardiomyopathy, enrolled on an on-going basis. Registry participants are invited to enter self-reported demographics and health data relevant to their cardiac diagnosis into The Heart Hive online database. Registry participants with self-reported clinically diagnosed dilated (DCM )or hypertrophic (HCM) cardiomyopathy will be recruited to an observational, prospective study entailing collection of patient-reported baseline demographic data and clinical risk factors, genotyping, and annual collection of follow up data from patients, national registries (NHS Digital) and medical records. In the pilot phase 100 DCM and 100 HCM patients will be recruited to a validation study. Consent will be sought to access medical information from health care providers in order to compare against and confirm self-reported health information. DNA will be obtained from saliva samples and tested in-house using a panel of clinically validated known Mendelian DCM and HCM genes as a second validation of the accuracy of self-reported diagnosis and to confirm equivalent genetic architecture of DCM and HCM in direct-to-patient recruited cohorts compared to traditional centre of excellence clinic-based recruitments. Following validation of the approach and once funding is in place for genomic studies, larger numbers of affected DCM and HCM patients will be recruited to this study from the registry of research willing participants. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04612296
Study type	Observational [Patient Registry]
Source	Imperial College London
Contact	Rachel Buchan, MD PhD
Phone	0 207 351 8144
Email	info@thehearthive.org
Status	Recruiting
Phase
Start date	November 9, 2019
Completion date	November 9, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05428787` - Resynchronization in Patients With HF in AF Trial Undergoing Pace & AVNA Strategy With LBBAP Compared With BiV Pacing	N/A
Not yet recruiting	`NCT05567445` - Outcome of Cardiomyopathic Adults Admission in ICU.
Completed	`NCT02555527` - Contrast Echocardiography Cost Effectiveness for Left Ventricular Thrombus Assessment	N/A
Completed	`NCT00371891` - Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS)	Phase 4
Recruiting	`NCT05552521` - Diastolic Dysfunction in Septic Shock and Cardiomyopathy Genetic Variants
Recruiting	`NCT04166331` - Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion	Phase 3
Terminated	`NCT06331507` - Refinement and Assessment of New MRI Technologies for Cardiovascular Exams Using the Phillips CMR Patch	N/A
Completed	`NCT01953523` - Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions	N/A
Recruiting	`NCT04695119` - Sepsis in the ICU-II
Completed	`NCT03228966` - Ped HIV - Echo Study: Kenya
Not yet recruiting	`NCT06348732` - Diagnostic and Prognostic Role of Troponin and Brain Natriuretic Peptide in Pediatric Patients With Cardiomyopathy in Correlation to Echocardiography Findings
Recruiting	`NCT05556369` - Genetic Characterization of Cardiomyopathies (POLICARDIOMIO2021)
Recruiting	`NCT04520646` - A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy	N/A
Not yet recruiting	`NCT03899298` - Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions	Phase 1
Completed	`NCT04323852` - Can Vitamin D Reduce Heart Muscle Damage After Bypass Surgery?	Phase 4
Completed	`NCT03527381` - Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery	Phase 1/Phase 2
Withdrawn	`NCT02462213` - Prospective Identification of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging	N/A
Active, not recruiting	`NCT00418041` - Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study)	N/A
Not yet recruiting	`NCT06091475` - Therapy to Maintain Remission in Dilated Cardiomyopathy	N/A
Recruiting	`NCT03317964` - Genetic Basis of Pacing-induced Cardiomyopathy